🟢 Capricor Therapeutics is trading 5.67% up with no clear catalyst identified

Capricor Therapeutics is trading at $8.19, up 5.67%, with no clear company-specific catalyst identified.

• The company’s October 5 announcement reported positive HOPE-3 extension data; a related webinar was scheduled for October 7. The timing does not establish the announcement as the cause of the session’s gain.
• Biotech was reported down, while major indexes were also lower. This risk-off backdrop does not explain the stock’s rise.